Header cover image

Hong Kong (HSI) Pharma Industry Analysis

UpdatedJan 29, 2023
DataAggregated Company Financials
Companies44
  • 7D1.6%
  • 3M28.8%
  • 1Y3.4%
  • YTD6.7%

In the last week, the Pharma industry is up 1.6%, with Hansoh Pharmaceutical Group up 2.9%. This takes the industry's 12 month performance to a gain of 3.4%. Looking forward, earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the Hong Kong Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 29 Jan 2023HK$645.5bHK$447.3bHK$35.6b10.8x18.1x1.4x
Tue, 27 Dec 2022HK$585.3bHK$442.0bHK$34.7b10.6x16.8x1.3x
Thu, 24 Nov 2022HK$576.4bHK$437.1bHK$33.9b9.2x17x1.3x
Sat, 22 Oct 2022HK$570.7bHK$512.7bHK$38.8b8.9x14.7x1.1x
Mon, 19 Sep 2022HK$528.7bHK$518.6bHK$40.6b9.2x13x1x
Wed, 17 Aug 2022HK$580.2bHK$512.3bHK$51.2b7.8x11.3x1.1x
Fri, 15 Jul 2022HK$634.3bHK$514.1bHK$52.1b8.5x12.2x1.2x
Sun, 12 Jun 2022HK$581.2bHK$514.2bHK$51.9b9.2x11.2x1.1x
Tue, 10 May 2022HK$553.5bHK$514.3bHK$51.4b8.1x10.8x1.1x
Thu, 07 Apr 2022HK$639.8bHK$525.2bHK$53.0b9.1x12.1x1.2x
Sat, 05 Mar 2022HK$641.0bHK$501.0bHK$45.2b9.4x14.2x1.3x
Mon, 31 Jan 2022HK$653.4bHK$497.0bHK$43.8b9x14.9x1.3x
Wed, 29 Dec 2021HK$704.8bHK$496.9bHK$43.8b9.7x16.1x1.4x
Fri, 26 Nov 2021HK$690.9bHK$495.9bHK$43.7b9.5x15.8x1.4x
Sun, 24 Oct 2021HK$730.7bHK$492.5bHK$42.8b10x17.1x1.5x
Tue, 21 Sep 2021HK$760.9bHK$489.7bHK$42.4b9.6x17.9x1.6x
Thu, 19 Aug 2021HK$852.0bHK$489.5bHK$42.4b11.9x20.1x1.7x
Thu, 03 Jun 2021HK$1.1tHK$463.7bHK$30.0b15.3x36.1x2.3x
Sun, 07 Mar 2021HK$953.9bHK$439.3bHK$27.7b12.4x34.4x2.2x
Wed, 09 Dec 2020HK$843.3bHK$424.8bHK$25.2b15x33.5x2x
Tue, 01 Sep 2020HK$853.8bHK$407.8bHK$27.1b17.1x31.5x2.1x
Fri, 05 Jun 2020HK$728.0bHK$416.7bHK$27.5b14.6x26.5x1.7x
Mon, 09 Mar 2020HK$720.7bHK$429.4bHK$27.1b14x26.6x1.7x
Price to Earnings Ratio

26.4x


Total Market Cap: HK$716.1bTotal Earnings: HK$27.1bTotal Revenue: HK$429.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Pharma Industry Price to Earnings3Y Average 22.5x202120222023
Current Industry PE
  • Investors are pessimistic on the Hong Kong Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 18.1x which is lower than its 3-year average PE of 22.5x.
  • The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 9.5% per year over the last three years, while revenues have remained mostly flat.
  • This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market2.72%
Healthcare1.88%
Pharma1.60%
Pharma1.60%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
3692 Hansoh Pharmaceutical GroupHK$17.282.9%
+HK$2.8b
10.3%PE32.6x
3320 China Resources Pharmaceutical GroupHK$6.223.7%
+HK$1.4b
68.1%PE9x
1177 Sino BiopharmaceuticalHK$4.911.4%
+HK$1.3b
-8.2%PE9.8x
867 China Medical System HoldingsHK$14.322.9%
+HK$980.8m
11.9%PE9.5x
6185 CanSino BiologicsHK$74.704.0%
+HK$715.6m
-39.8%PE150.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

950

HK$2.00

Lee's Pharmaceutical Holdings

7D

-3.4%

1Y

-32.2%

2005

HK$5.03

SSY Group

7D

-2.3%

1Y

49.3%

2096

HK$10.56

Simcere Pharmaceutical Group

7D

-0.9%

1Y

42.5%

3737

HK$1.05

Zhongzhi Pharmaceutical Holdings

7D

-6.3%

1Y

9.4%

570

HK$3.88

China Traditional Chinese Medicine Holdings

7D

-0.3%

1Y

-11.4%

2186

HK$3.84

Luye Pharma Group

7D

3.8%

1Y

15.7%

1177

HK$4.91

Sino Biopharmaceutical

7D

1.4%

1Y

-8.2%

1477

HK$9.96

Ocumension Therapeutics

7D

-1.8%

1Y

-13.2%

6185

HK$74.70

CanSino Biologics

7D

4.0%

1Y

-39.8%

1093

HK$9.41

CSPC Pharmaceutical Group

7D

0.6%

1Y

3.4%

719

HK$6.81

Shandong Xinhua Pharmaceutical

7D

-0.9%

1Y

62.1%

6622

HK$5.65

Zhaoke Ophthalmology

7D

19.7%

1Y

17.0%

6660

HK$23.30

AIM Vaccine

7D

-1.7%

1Y

n/a